Our featured content

Tech – Sep 27, 2023

Unlocking Startup Potential: The Vi Partners 4Ps Blueprint

At Vi Partners, we're not just about crunching numbers; we're treasure hunters. What are we digging for? The future leaders of the B2B SaaS universe, particularly in Europe and Switzerland.

Healthcare – Aug 14, 2023

Xeltis secures additional €12.5 million from European Innovation Council Fund in final close of D2 financing

Funding extends Xeltis’ Series D2 financing round to €44.5 million.

Healthcare – Aug 08, 2023

Oculis announce positive results from a Phase 3 OPTIMIZE trial showing that a daily does of OCS-01 eye drops treats inflammation and pain following cataract surgery

OCS-01, First Investigational Eye Drop for Front and Back of the Eye, Met Both Primary Endpoints in Phase 3 OPTIMIZE Trial with a Once Daily Regimen for the Treatment of Inflammation and Pain Following Cataract Surgery Once daily OCS-01 meets primary endpoints demonstrating superior reduction in inflammation and pain vs. vehicle following cataract surgery OPTIMIZE’s results follow the positive and statistically significant top line results from stage 1 of the Phase 3 DIAMOND trial in Diabetic Macular Edema (DME) reported earlier this year, further highlighting the product’s potential for treating front- and back-of-the-eye diseases

Healthcare – Jul 12, 2023

Empowering Breast Cancer Screening Globally - Why we invested in Vara

Last year, Vi Partners led a Series A2 round in Vara (www.vara.ai), a pioneering company focused on democratising breast cancer screening and improving women's healthcare outcomes. We are thrilled to partner with Vara's exceptional team, who are driven by the ambition to transform how breast cancer screenings are conducted, ensuring accessibility, accuracy, and a patient-centric approach.

Healthcare – Jul 05, 2023

Building the digital healthcare enterprise ecosystem – customer by customer

Giving European Healthcare enterprises, a digital upgrade is hard. Let’s explore the challenges and some of the lights on the horizon. The prosperity and health of all of us depends on keeping our health care systems effective. To make sure this is achieved and remains affordable, we need to leverage digital transformation.

Healthcare – May 22, 2023

Oculis Announces Positive Top Line Results

Oculis Announces Positive Top Line Results from DIAMOND Stage 1 Phase 3 Trial in Diabetic Macular Edema with OCS-01 Eye Drops

Technology – Feb 27, 2023

Why did we invest in time management application Morgen.so?

Last summer, the Vi Partners technology team led a pre-seed round in Morgen.so. We are delighted to partner with a ground breaking time management application built by a stellar team that has the ambition to transform how knowledge workers deal with their time, boost their productivity while improving their worklife balance and overall wellbeing.

Healthcare – Feb 21, 2023

Xeltis raises €32 million to drive clinical development of world’s most advanced restorative cardiovascular devices

Xeltis, a clinical stage medtech company developing living implants that enable the body to restore cardiovascular function, announces that it has raised €32 million in a Series D2 equity fundraise.

Tech – Jan 23, 2023

Switzerland-Based Acodis Closes CHF 6 million Series A Funding Round to Transform Document Processing for Pharma and Health

The Swiss AI start-up Acodis closed a CHF 6m financing round from existing and new investors. Acodis, the leading Intelligent Document Processing (IDP) platform, raised CHF 6 million in a Series A funding round led by Hi Inov and VI Partners. The new funds will be used to further expand Acodis' position as the leading Document Processing Platform for the Pharma and Health sector.

Latest News

Our credo

Entre­preneurs improve the world. We proudly support them.

Our heritage

Who we are and how we started 

Vi Partners' founding team came together in 2000 to advise Venture Incubator, an investment vehicle initiated by ETHZ and funded by ten blue-chip Swiss companies. Today, we advise funds investing across Europe in tech and healthcare.